In this episode of The BioHub Podcast, Max sits down with Randy Teel, President and CEO of Arvinas.


Randy joined Arvinas in 2018 as Vice President of Corporate Development and has since helped guide the company through a period of significant growth, ultimately stepping into the CEO role. Today, Arvinas is one of the pioneers in targeted protein degradation, using its PROTAC platform to develop therapies designed to eliminate disease-causing proteins.


In this conversation, we discuss Randy’s journey from strategy and corporate development into the CEO seat, the evolution of Arvinas from an emerging platform company to an industry leader, and the challenges of building and scaling a biotech company.


We also explore the future of targeted protein degradation, the company’s unique partnership approach, and what’s next for Arvinas and its pipeline.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Max Brennan - Biotech HeadHunter. Innehållet i podden är skapat av Max Brennan - Biotech HeadHunter och inte av, eller tillsammans med, Poddtoppen.